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Abstract
Bacterial transcription activators of the XylR/DmpR subfamily exert their expression control via s54-dependent RNA
polymerase upon stimulation by a chemical effector, typically an aromatic compound. Where the chemical effector interacts
with the transcription regulator protein to achieve activation is still largely unknown. Here we focus on the HbpR protein
from Pseudomonas azelaica, which is a member of the XylR/DmpR subfamily and responds to biaromatic effectors such as 2-
hydroxybiphenyl. We use protein structure modeling to predict folding of the effector recognition domain of HbpR and
molecular docking to identify the region where 2-hydroxybiphenyl may interact with HbpR. A large number of site-directed
HbpR mutants of residues in- and outside the predicted interaction area was created and their potential to induce reporter
gene expression in Escherichia coli from the cognate PC promoter upon activation with 2-hydroxybiphenyl was studied.
Mutant proteins were purified to study their conformation. Critical residues for effector stimulation indeed grouped near the
predicted area, some of which are conserved among XylR/DmpR subfamily members in spite of displaying different effector
specificities. This suggests that they are important for the process of effector activation, but not necessarily for effector
specificity recognition.
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Introduction
Transcription activators of the XylR/DmpR subfamily of s54-
dependent regulatory proteins play pivotal roles in controlling
gene expression in bacterial aromatic compound catabolism [1,2].
Classical and very well characterized examples include XylR, the
primary activator for the xyl genes of the TOL plasmid for toluene
and xylene degradation in Pseudomonas putida mt-2 [3], DmpR, the
sole transcription activator of the dmp genes for phenol and o-cresol
metabolism in Pseudomonas sp. strain CF600 [4], and TouR, from
Pseudomonas stutzeri OX1 [5]. A large number of more diverse
members of the same subfamily have been identified in the course
of the recent years, among which are PhnR from Burkholderia
sartisoli RP007 (regulating phenanthrene metabolism) [6], HbpR
from ‘Pseudomonas azelaica’ (activating 2-hydroxybiphenyl metabo-
lism) [7] and TbuT from Burkholderia pickettii PKO1 [8].
XylR/DmpR subfamily members belong to the even larger class
of NtrC-type transcription regulators, which are involved in a variety
of physiological processes in response to diverse environmental
signals [9]. Generally, these transcriptional activators act at a
distance of 100 to 200 bp from the actual promoter by binding to
what are called enhancer-like elements or upstream activating
sequences (UAS) [10]. In addition, they specifically interact with s54
RNA polymerase [1]. A further hallmark of proteins from this family
is the presence of two conserved domains, one of which is called the
central C-domain and contains a triple-AAA ATPase motif [11].
The C-domain is supposed to interact with s54 RNA polymerase
and hydrolyzes ATP, perhaps to facilitate open transcriptional
complex formation. The second conserved feature of these proteins
is a carboxy terminal D-domain, which contains a typical helix-turn-
helix DNA binding motif and is implicated in interaction with the
UAS-DNA [12]. In contrast to NtrC, members of the XylR/DmpR
subfamily have a distinct N-terminal or A-domain necessary for
recognition of chemical effector molecules that unleashes activity of
the transcription activator [13]. A further small region called the B-
domain or Q-linker because of its abundance in glutamine residues,
connects the A- and the C-domain. It is supposed to act as a flexible
molecular hinge, releasing intramolecular repression by the A-
domain and exposing the ATP-ase activity of the C-domain upon
recognition of the effector [14]. Indeed, XylR and DmpR mutants
devoid of their A-domain act as constitutive transcription activators
on their cognate promoters [15,16]. Importantly, however, an A-
domain deletion of the distantly related HbpR protein (see below) is
constitutively repressed [17].
Despite extensive genetic and biochemical data on XylR and
DmpR, there is still no clear picture on the A-domain residues
implicated in effector interaction, neither does a clear hypothesis
exists on the mechanism of effector-mediated triggering of the
activation process. Most information so far comes from the
analysis of XylR and DmpR, from screening of spontaneous
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mutants [18], of mutants obtained by directed evolution [19] or by
DNA family shuffling [13,20], and of mutants obtained by site-
directed mutagenesis [21]. Attempts to obtain direct structural
information on the proteins of this subclass have been frustrated by
the difficulty to purify and stabilize the full protein. Nevertheless, a
structural model for the XylR A-domain was proposed based on
low but pertinent similarity to the A-chain of eukaryotic catechol
O-methyl transferase [22]. This model, however, consists of only a
single XylR A-domain protomer whereas the current hypothesis
predicts that proteins from this class undergo an activation cycle of
multimerization and multimer disassembly [23].
The goal of the current work was to identify the residues critical
for effector-mediated triggering in the HbpR protein from P.
azelaica [7,17]. In its native host, the hbpR gene product regulates
expression from two promoters, called the PC and PD promoters,
which are located in front of two small operons (hbpCA and hbpD)
encoding the enzymes for initial steps of 2-hydroxybiphenyl (2-
HBP) degradation (Fig. 1A) [24]. The hbpR gene is located directly
upstream of and is divergently oriented from the hbpCA genes.
HbpR displays only 37% amino acid sequence identity with XylR,
and in contrast to XylR and DmpR, is responsive to biaromatic
compounds such as 2-HBP, 2,29-dihydroxybiphenyl, 2-aminobi-
phenyl and 2-hydroxydiphenylmethane [7]. XylR and HbpR
display detectable but little crossbinding to each other’s DNA
binding sites although hybrid promoters can be produced that are
activated by both XylR and HbpR in the same cell [25]. In
contrast to XylR and DmpR, the Q-linker of HbpR is shorter and
A-domain deletions of HbpR result in a constitutive repressor
protein [17]. Since such A-domain deletions are made without any
protein structure basis, it is possible that they accidentally produce
different effects in HbpR and XylR or DmpR.
In order to decipher possible determinants in the A-domain of
HbpR for 2-HBP-mediated triggering, we assumed that 2-HBP
would interact with specific residues exposed to the A-domain surface.
To make a more rational guess on the choice of residues to investigate,
we expanded the modeling approach previously developed for the A-
domain of XylR [22] to predict a tertiary structure for that of HbpR,
and predicted the regions of possible 2-HBP interaction using small
ligand docking approaches. Amino acid residues in the predicted
effector-interaction region and in control regions outside were
changed by site-directed mutagenesis. The integrity and activation
potential of the resulting mutant proteins by the natural effector 2-
HBP and the two non-natural effectors toluene and 2-chlorobiphenyl
was tested in an Escherichia coli based heterologous expression system.
Our results essentially confirm the modeling hypothesis and expand
our understanding of several critical residues in not only in HbpR but
in XylR and DmpR for effector interaction.
Results
Prediction of A-domain folding and the 2-HBP interaction
site on HbpR
To make a rational prediction of which amino acids in the
HbpR A-domain could be implied in effector interaction, its
tertiary structure was modeled. Because no crystal structure of the
effector binding domain of HbpR or close relative has been
determined, the domain was modeled using a bioinformatics
approach similar as proposed earlier for XylR [22]. Directly fitting
a tertiary structure model for the HbpR A-domain failed because
of too low homology to any existing structures in the PDB
database [26]. The first 218 amino acids of HbpR were thus
structurally aligned to the XylR and DmpR A-domain computa-
tional models [22] as templates using the program SWISS-MODEL
[26,27]. The computed HbpR A-domain model for the amino
acids 9-211 displayed eight alpha helices and five beta strands
(Fig. 1B, C). As expected using these templates, the predicted
shape for the HbpR A-domain was highly similar to those of XylR
and DmpR with exception of a few loops (Fig. 1D, E). The HbpR
A-domain C-terminal end is predicted to be coiled instead of
forming beta sheets as in XylR and DmpR, but it should be noted
that the model does not take the A- and C-domain connection of
the protein into account. Interestingly, the HbpR A-domain model
Figure 1. Overview of the hbp regulatory system and tertiary
structure modeling of the HbpR A-domain using a previously
established XylR model as template. (A) Organization of the hbp
genes and the location of the HbpR binding sites (UAS, upstream
activating sequences) in front of the PC and PD promoters. HbpR
domains are depicted to scale according to the predictions by Jaspers
et al [7]. (B) to (E) Fitting used SWISS-MODEL and was performed on XylR A-
domain PDB coordinates as calculated by Devos et al [22]. (B) Ribbon
model of HbpR A-domain residues 11–209, with predicted coils, alpha-
helices and beta-sheets indicated. (C) Superposition of the predicted
HbpR and XylR A-domains in the same configuration as A. (D) Tertiary
structure model of HbpR A-domain with calculated molecular surface at
1.4A˚ and 40% transparency, in order to see the helical, coil and sheets.
Model turned into a position which enables visualization of the
proposed tunnel entry (b). C-terminal end of coil ending the A-domain
indicated with an arrow at (a). Pinkish region in the centre of the A-
domain illustrates a predicted cavity within the A-domain. (E), as C but
now for the XylR A-domain, with exception of the ten most C-terminal
residues, which otherwise are predicted to occlude the tunnel.
doi:10.1371/journal.pone.0016539.g001
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predicted one face of the tertiary structure to have an overall more
negative electric potential than the opposite face, which may favor
dimeric A-domain interactions (not shown).
The A-domain model for HbpR was then used as a template to
predict the possible sites of interaction with its effector 2-HBP
(Fig. 2A, D, E). Potential sites for 2-HBP interaction were
calculated by using the program GRAMM, which uses Fast Fourier
transformation to predict the energetically most favorable matches
of a ligand on the modeled protein surface [28]. Interestingly,
GRAMM calculations predicted that there would be an ‘interface’
region most favorable for interaction with 2-HBP rather than a
single residue or active site, which upon closer inspection of the
model seemed to provide a cavity (Fig. 2A). Among one thousand
iterations, the program predicted almost exclusively interactions in
this particular region. A number of amino acid residues such as
E184 were located in this region (Fig. 2A, B), which upon mutation
in XylR had been demonstrated to broaden effector-mediated
induction [29]. In addition, a similar region had been predicted
from the XylR A-domain model to be of potential interest to
effector binding, even though few mutations had been generated
in that part of the protein [22]. The main hypothesis in this work
was therefore that this interface region would be critical for 2-
HBP-mediated triggering of HbpR activation.
Design and construction of HbpR mutants
Two groups of mutations were created to validate or refute our
hypothesis: a first group, which concentrated on a number of
amino acid residues in this region conserved between HbpR, XylR
and DmpR. Mutations in this group were designed to alter the
chemical nature of the residue (i.e., charged to non-charged,
hydrophobic to hydrophilic). In the second group we designed
mutations, which would ‘block’ the cavity by the bulky amino acid
phenylalanine. Because such drastic replacements by Phe could
have secondary effects on protein performance, we created a
number of control mutations on residues not predicted to be
directly at the cavity interface (Fig. 2).
An overview of all mutants constructed in the first and the
second group is presented in Table 1. All mutations in the HbpR
A-domain were constructed by PCR with mutated oligonucleo-
tides and verified by DNA sequencing. Subsequently, the mutated
A-domain sequences were used to replace the gene region for the
native A-domain in hbpR on an expression vector in E. coli, with
which we could test 2-HBP inducible egfp expression under control
of the HbpR-dependent PC promoter. This expression vector
results in the addition of a His6-tag to the N-terminal end of the
protein. All mutants were tested in E. coli for EGFP expression
during exponential growth in the presence or absence of 20 mM 2-
HBP, which is the cognate effector for the HbpR-PC system.
Table 1 gives representative EGFP induction values after 2 and
4 h induction time compared to those of the strain carrying wild-
type HbpR. In general and for all mutants, we observed four types
of effects: (i) complete loss of activation with respect to the wild-
type (type I), (ii) two-fold loss of induction potential in 2 h but not
4 h incubation periods (type II), (iii) no effect compared to the
Figure 2. Details of the modeled tertiary structure of the HbpR A-domain, showing amino acid residues that were mutated in this
study and the region onto which 2-HBP is predicted to be bound. (A) Results of 1000 iterations of 2-HBP (in red) docking calculations using
GRAMM onto the predicted HbpR A-domain protein surface, whilst indicating the position of residues altered to Phe. (B) Close-up of the same, but
without the docked 2-HBP positions. (C) as for B, now highlighting the other changed residues. (D) Van der Waals-filled model slightly turned
compared to A, in order to indicate the region of 2-HBP docked molecules. (E), as B, but with 2-HBP docked positions. (F) Turned van der Waals-filled
model showing the tunnel from the other side of the entry.
doi:10.1371/journal.pone.0016539.g002
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wild-type (type III), and (iv) considerable increase of background
expression (type IV, Table 1, Fig. 3). Protein extracts of the same
strains were analyzed by Western blotting using an M13-VHH
camel antibody to verify (mutant) HbpR expression (Fig. 4).
Surprisingly, all Westerns showed two bands, which likely
correspond to His6-tagged HbpR (or mutant, 64.1 kDa) and
HbpR (mutant) without His6-tag (62.8 kDa). The reason for the
production of two N-terminally different HbpR proteins probably
lies in the use of an alternative start codon further downstream.
The expression level of most HbpR mutant proteins in E. coli was
similar to the wild-type, except for L207F (low outlier) and E203P
(high outlier) (Fig. 4; Text S1).
The first group of mutations directed to changing the chemical
character of conserved residues among XylR/DmpR/HbpR A-
domains produced the following results. E184L (equivalent
position in XylR E172, Text S1) completely abolished EGFP
expression from the HbpR dependent PC promoter (type I). To a
lesser extent, also mutations V182T and I180T drastically reduced
EGFP induction upon 2-HBP addition – mostly after 2 h, but after
4 h induction time the difference to the wild-type was less
pronounced (type II, Table 1, Fig. 3). Other residues, mutation of
which reduced activation potential by 2-HBP, were I56T, E203L,
E203Q and E209L (Table 1). By contrast, mutation of the
chemical character of residues in this vicinity, e.g., W205H,
V181T, L60N, Q188E and I185T, did not significantly affect 2-
HBP-dependent activation in E. coli (type III). Interestingly,
changing Ala202 to Ser resulted in a fourfold higher EGFP
expression in the absence of 2-HBP as compared to wild-type
HbpR (type IV). This suggested that several residues in this area
indeed affected activation of expression by 2-HBP, but only
Glu184 seemed absolutely critical.
Next, we created Phe-substitutions in a number of residues in
the predicted interface area, which we suspected could ‘block’ a
cavity seen on the surface of the model. As controls, a number of
randomly chosen other residues were also substituted by Phe
(Fig. 2D). The effect of those mutations was again analyzed by
Table 1. Fluorescence intensities in Escherichia coli expressing EGFP from PC under control of HbpR wild-type or its mutants, in the
presence or absence of 2-hydroxybiphenyl.
Mutant Class Residue 2 h induction time 4 h induction time
NIa Ratio to WTInduced IF NI
Ratio to
WT Induced IF
I Cys187Phe 505618b 0.96 582653 1.2 538614 0.97 597618 1.1
I Glu184Phe 487621 0.92 615692 1.3 589623 1.06 648613 1.1
I Glu184Leu 536611 1.01 657643 1.2 603643 1.08 648613 1.1
I Thr52Phe 544621 1.03 665614 1.2 639624 1.15 1411672 2.2
II Ile180Phe 577612 1.09 723621 1.3 688622 1.24 59936253 8.7
II Val182Thr 537618 1.02 878684 1.6 572623 1.03 6513635 11.4
II Ile180Thr 458617 0.86 1709648 3.7 474617 0.85 38546100 8.1
II Leu207Phe 482618 0.91 1213653 2.5 542625 0.97 57336144 10.6
II Ile56Thr 481616 0.91 21616167 4.5 582616 1.05 65506139 11.3
III Glu203Leu 544618 1.03 2731680 5.0 662621 1.19 85716146 12.9
III Gln209Leu 546621 1.03 29776127 5.5 697632 1.25 83316162 12.0
III Glu42Phe 472611 0.89 27926225 5.9 497627 0.89 78536125 15.8
III Glu203Gln 569614 1.08 31526147 5.5 751629 1.35 101416650 13.5
III Glu203Pro 580614 1.1 31476178 5.4 754634 1.35 111206530 14.7
III Val50Phe 493612 0.93 31516104 6.4 574629 1.03 8028691 14.0
III Lys178Phe 510611 0.96 33346169 6.5 611623 1.09 85676145 14.0
III Wild-type 529621 1 35036260 6.2 557621 1 88586195 15.9
III Trp205His 540619 1.02 35546231 6.6 673632 1.21 89316263 13.3
III Val181Thr 563612 1.06 35896136 6.4 690641 1.24 95366257 13.8
III Leu60Asn 511613 0.97 36156103 7.1 618616 1.11 94436172 16.0
III Glu183Phe 547618 1.03 36536136 6.5 683638 1.23 9903687 14.5
III Glu183Gln 595615 1.12 38366125 6.5 730629 1.31 94936126 13.0
III Gln188Glu 692611 1.31 38536146 5.6 839642 1.51 107666118 12.8
III Ile185Thr 470616 0.89 38966163 8.3 548621 0.98 80946218 14.8
III Gln209Phe 456623 0.86 39506165 8.7 612618 1.09 74656187 12.2
IV Val181Phe 1049626 1.98 43686104 4.2 1647663 2.96 101856212 6.2
IV Ser32Phe 828619 1.56 46266108 5.6 1598672 2.87 114326283 7.2
IV Ala202Ser 2184635 4.18 51566153 2.4 1923657 3.45 110726157 5.8
a), NI, non induced conditions and ratio of NI-fluorescence in mutant and that of wild-type; IF, induction factor, calculated by dividing culture fluorescence with 2-
hydroxybiphenyl by that of the culture in the absence of 2-hydroxybiphenyl.
b) Averages from biological triplicates with calculated standard deviation.
doi:10.1371/journal.pone.0016539.t001
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HbpR-dependent 2-HBP-inducible EGFP expression in E. coli
(Table 1). As for mutant E184L, also E184F completely abolished
inducible egfp expression from PC. Similar effects were caused by
mutations C187F and T52F. Phenylalanine substitutions in Ile180
and Leu207 resulted in the delayed induction phenotype (type II).
Mutations in the majority of residues had basically no effect on the
magnitude or kinetic induction with 2-HBP (Glu51, Val50,
Lys178, Glu183 and Gln209). All of these were located more or
less in the vicinity of the proposed cavity (Fig. 2C, D), but not as
close to the 2-HBP interaction region as, e.g., Thr52, Ile180,
Val182 or Glu184. Interestingly, two Phe substitions (at Ser32 and
Val181) produced HbpR-mutants with higher background
expression in the absence of 2-HBP (type IV, Table 1, Fig. 3).
For a number of residues multiple substitutions were created,
which almost in all cases produced the same effect. Both mutations
in Glu184 (to Phe or to Leu), abolished induction with 2-HBP, and
also both mutations in Ile180 (to Phe or to Thr) decreased 2-HBP
induction (Table 1). All mutations created in Glu203 (to Leu, Gln
and Pro) were more or less without large effect on 2-HBP
induction. Also both mutations in Glu183 (Phe and Gln) produced
the same effect. On the contrary, Val181Thr had no effect, but
Val181Phe produced a higher non-inducible background. The
same was found for Gln209, for which a change to Leu reduced,
but change to Phe slightly increased the magnitude of egfp
induction with 2-HBP.
HbpR mutant integrity
Western blotting with an anti-HbpR M13-displayed VHH camel
antibody suggested (within the accuracy of this technique) that
most HbpR mutant proteins were produced to the same level in E.
coli (Fig. 4), except for L207F (lower than expected) and E203P
(higher than expected). This indicated that differential EGFP
expression in E. coli carrying a mutant hbpR gene was not due to
complete misfolding or degradation of the protein, but rather due
to a critical amino acid change in the effector binding region. In
particular E184L, I180T, I180F, T52F and C187F, which were
the mutations causing the largest decrease of 2-HBP-dependent
Figure 3. Exemplary effects of HbpR A-domain mutations on inducible expression. Measured fluorescence intensities of Escherichia coli
cells carrying a plasmid with a promoterless egfp under control of the HbpR-dependent PC-promoter in the presence or absence of 20 mM 2-HBP as
inducer. EGFP expression was measured on whole cells at two time points and corrected for culture turbidity. Type I to IV correspond to differently
shaded entries in Table 1. Note the delayed response in Type II mutants and the higher background in the absence of inducer in type IV mutants.
doi:10.1371/journal.pone.0016539.g003
Figure 4. HbpR (mutant) expression in E. coli from pHBP269A0-
plasmids, i.e., those which were used for 2-HBP induced EGFP
expression from PC. Coo, Coomassie-Blue-stained SDS-PAGE
gel fragment around 67 kDa. a-HbpR, bands on gel detected in
Western blotting with anti-HbpR antibodies. Relevant mutations
are indicated; note that wild-type and several mutants were analyzed
twice. Numbers below the gel fragments indicate the average
normalized intensities of both HbpR bands for each mutant or wild-
type. Those numbers highlighted in white on black background point
to values below or above the 25 and 75% quantiles of all measured
intensities.
doi:10.1371/journal.pone.0016539.g004
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EGFP expression from PC, resulted in HbpR mutant proteins that
were expressed in E. coli within the normal range observed for all
(Fig. 4). To corroborate this further, we purified a number of
(mutant) HbpR proteins and compared their circular dichroism
spectra between 200 and 250 nm. Sixteen mutant HbpR proteins
and HbpR wild-type (all tagged with His6) were hereto purified by
Ni-NTA chromatography, dialysed and diluted to 0.3 mg protein
per ml (Fig. 5). For reasons of protein stability, it was not possible
to completely omit traces of EDTA and glycerol from the dialysis
buffer. As a result no reliable spectra below 198 nm could be
recorded (not shown).
Whereas identical spectral traces are usually interpreted as
proteins having the same solution conformation, the HbpR wild-
type and 15 mutant proteins produced similar but not identical
traces. Broadly we detected three types of spectra in the region
between 205 and 240 nm (Fig. 5). Most mutant proteins differed
very little from the HbpR wild-type circular dichroism (Fig. 5B).
Three mutants (V182T, L207F and T52F) deviated specifically in
the region 206–212 nm (Fig. 5A), and mutants C187F, E184L,
E42F, E203P and I56T differed more strongly in the region 205–
220 nm (Fig. 5C). This indicates, therefore, that some HbpR
mutant proteins adopt different configurations than HbpR wild-
type (folding, or multimerization in solution). However, since
mutant and wild-type protein expression in E. coli was more or less
similar (except for L207F and E203P), we conclude that different
circular dichroism profiles reflect the immediate refolding effect of
a mutation but are not indicative for complete misfolding, or else
the phage antibody would not have recognized the protein.
Moreover, a number of mutant HbpR proteins with slightly
different scans still retained normal induction potential. For
example, E203P and E42F showed circular dichroism scans clearly
different from wild-type HbpR and similar to C187F and I56T.
Yet, E203P and E42F maintained induction potential similar as
wild-type HbpR, whereas C187F and I56T were impaired
(Table 1). By contrast, proteins V182T, L207F and T52F were
all impaired in activation potential and their circular dichroisms
differed from wild-type. Therefore, we conclude that some
mutations cause different partial folding, but this does not
necessarily lead to an overall change in protein configuration
such that it renders the protein inactive and would cause the lack
of induction with 2-HBP. Thus, effects on 2-HBP-dependent
EGFP expression from PC must have been the genuine
consequence of a change in a critical effector binding region or
residue.
Complementation of the mutants with the wild type
HbpR
Next, we tested whether the created HbpR mutations were
dominant over wild-type HbpR, which would be a further
indication for their activity in E. coli, since we previously
demonstrated that an HbpR mutant devoid of the A-domain
was dominant negative on wild-type HbpR [17]. Hereto, the A-
domain mutant strains of HbpR in E. coli were complemented with
a plasmid expressing wild-type hbpR from its native promoter
(pHBP124). For all type I mutants (loss of induction), comple-
mentation with wild-type HbpR restored 2-HBP inducible activity
although not to the level of wild type response (Fig. 6). Mutants
C187F and I180F reverted to 3/4th of the lost activity upon
complementation with wild-type. This might be the result of
formation of heteromultimers between wild-type HbpR and
mutant protomers, which do not fully restore functionality. It is
worth noticing that for mutations W205H, I185T and Q188E,
which did not affect the activity of the protein, complementation
reduced the response to 2-HBP. This effect could also be seen with
the semi-constitutive mutants A202S, V181F and S32F; comple-
mentation with the wild-type HbpR decreased the response upon
induction (Fig. 6). Such mutations may therefore affect heterodi-
mer formation.
Figure 5. Circular dichroism spectra of purified His6-tagged HbpR wild-type protein or of sixteen purified HbpR A-domain mutants,
between 200 and 250 nm, at a protein concentration of <0.3 mg/ml. Spectra were normalized to De, as indicated in the Experimental
Procedures section, and grouped to reveal similar dichroism trends. (A) HbpR wild-type and mutants V182T, L207F and T52F (type II effects with
delayed and lower induction by 2-HBP). (B) Mutants with similar dichroisms as HbpR wild-type. (C) Mutants with the most strong aberration of the
wild-type circular dichroism trace, of which C187F and E184L completely abolished activation by 2-HBP, but E42F and E203P having no major effect
on 2-HBP dependent induction in E. coli.
doi:10.1371/journal.pone.0016539.g005
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Finally, we tested whether any of the mutants were different in
response to aromatic compounds not known to activate wild-type
HbpR. Hereto we chose 2-chlorobiphenyl (at 100 mM), which is
the effector for certain HbpR mutants obtained by directed
evolution approaches [30], and toluene (at 20 mM), which is an
effector for XylR. Incubation of the HbpR mutant series or wild-
type in E. coli with 2-chlorobiphenyl did not produce any
significant induction compared to non-amended cultures (not
shown). None of the mutants or wild-type were responsive to
toluene either. Toluene (at 20 mM) reduced by 10% the induction
obtained with 32 mM 2-HBP in a co-induction assay for wild-type
HbpR and the mutants I180F, V181T, I185T, E203L, E203Q
and W205H (not shown). In a few other mutants (I56T, E183F
and K178F) coincubation with 20 mM toluene and 32 mM 2-HBP
enhanced EGFP expression by<20% compared to 32 mM 2-HBP
alone. This indicates that the created mutations do not ‘widen’ the
effector spectrum.
Discussion
Although previous work by several groups have clearly demon-
strated the importance of the A-domain of proteins of the XylR/
DmpR subfamily of transcription activators in effector recognition,
the actual effector ‘binding’ region and the type of effector interaction
have largely remained elusive. A plethora of A-domain mutations has
been produced for XylR and DmpR (Text S1), which highlighted
several residues in activation function. A conceptual breakthrough
was proposed by Devos and coworkers in 2002, who developed a
structural model for the XylR (and DmpR) A-domains on the basis of
a weak but significant structural homology to catechol O-demethylase
from Rattus norvegicus. Placement of the various mutated residues and
their effects on the modeled structure seemed to indicate that the A-
domain is highly ‘prone’ to allow changes in effector recognition but
at various unexpected secondary positions. More recently, this
formed the basis to hypothesize that this domain readily adopts a stem
protein configuration of ‘open’ flexibility towards new effector
substrates [19].
In this work we extended the structural model of the XylR A-
domain to predict that of the distantly related protein HbpR. Even
though the basis for structural modeling of the A-domain is weak
and only based on the alignment of the HbpR A-domain to the
model of XylR A-domain, which on its turn is based on that of
catechol O-demethylase (PDB entry 1vid), it allowed us to formulate
a direct testable hypothesis for the implication of a number of amino
acid residues in 2-HBP recognition. On the basis of the structural
prediction and subsequent calculation of the energetically most
favorable region for interaction of 2-HBP on the modeled protein
surface by GRAMM [28], we identified one region with an exposed
cavity (Fig. 2E, F). Indeed, site-directed mutagenesis of residues in
this area identified several critical and non-critical amino acids for 2-
HBP-mediated HbpR activation of the PC-promoter (Text S1).
Notably, these were Glu184, emphasizing a residue with also
critically conserved importance in XylR and DmpR (Text S1),
Cys187 (conserved), and Ile180 (conserved), both of which had not
been detected previously by mutagenesis on XylR or DmpR. Other
residues, mutation of which reduced but not completely abolished
activation potential by 2-HBP, were Ile56, Val182 and Leu207
(Text S1). HbpR-L207F seems to be produced less efficiently in E.
coli (Fig. 4), but the other mutant HbpR proteins were were correctly
produced in E. coli, albeit with detectable folding differences (Fig. 5).
Hence, we conclude that these residues are of critical importance to
2-HBP effector mediation in HbpR. Since our in vivo assays only
measure the outcome of 2-HBP-mediated activation by HbpR
(mutants) on PC-expression, we cannot conclude whether those
amino acid residues are implicated in 2-HBP ‘binding’ or in some
other step of the activation pathway.
Highly speculatively, but still interesting, was the prediction of a
cavity in the structural model of the HbpR A-domain surface
where 2-HBP would interact. The importance of this cavity for 2-
HBP mediated activation of HbpR was investigated further by
systematically changing its residues (i.e., Val50, Thr52, Ile56,
Leu60, Leu207 on one side, and Ile180, Val181, Val182, Glu183,
Glu184, Ile185, Cys187, Gln188). Perhaps atypically, we chose to
change residues in this region to the bulky phenylalanine with the
prospect that such a bulky residue might physically block entry of
2-HBP to the cavity. However, some residues were changed
multiple times, not only to phenylalanine but to less bulky residues,
which essentially produced the same in vivo effects (Table 1, Text
S1). Because bulky residues may change more than only the entry
to the cavity we produced a number of control Phe-substitutions
outside this region and analyzed HbpR mutant protein production
in E. coli. Indeed seven substitutions severely impaired or abolished
2-HBP induction in E. coli (Ile56, Thr52, Ile180, Val182, Glu184,
Cys187 and Leu207), whereas substitutions to residues positioned
outside on the surface (Ser32, Glu42, Val50, Lys178) did not. Of
all these, Ile180, Glu184 and Cys187 are conserved among XylR,
DmpR and HbpR, whereas Thr52 is not (Text S1). Contrary to
those critical residues, changes in Glu203, Glu183, Val181,
Trp205 and Gln209 had no major effects, even though they were
predicted to be near the cavity. It is likely that HbpR proteins with
these mutations in their A-domains adopted slightly different local
configurations than wild-type, as was demonstrated from circular
dichroism scans of purified proteins (Fig. 5), but Western results
did not indicate that this misfolded the protein completely (Fig. 4).
Furthermore, certain Phe-substitution mutants with altered CD
scans compared to wild-type HbpR did not display loss of function
(Fig. 5, Table 1). Therefore, even though it is difficult to
unequivocally decide whether bulky mutant residues cause loss
Figure 6. EGFP expression from the HbpR-dependent PC-
promoter in E. coli in the presence (black bars) or absence
(grey bars) of 2-HBP as inducer measured for the different
HbpR A-domain mutants after 2 h induction time, and either
complemented with a second plasmid carrying wild-type HbpR
(pHB240) or not. Note the partial ‘rescue’ of the abolished phenotype
in T52F, I180F, E184F, C187F and V182T by wild-type HbpR, suggesting
that the mutant proteins are not dominantly negative over the wild-
type. Results indicate the mean of triplicate incubations, plus the
calculated standard deviation.
doi:10.1371/journal.pone.0016539.g006
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of function because they change a critical residue or because they
partial unfold the protein, our results suggests that this region is
indeed a very critical one for proper 2-HBP-mediated activation of
HbpR and that its most essential residues are Thr52, Ile180,
Glu184 and Cys187. Interestingly, mutations in such residues did
not change the effector spectrum of HbpR and neither did the
other generated mutations, whereas previous mutations obtained
by directed evolution of HbpR that did change the effector
spectrum from 2-HBP to 2-chlorobiphenyl mapped in completely
different areas of the A-domain (Text S1). Only some mutations,
e.g. Ala202, mapped in a region which by directed evolution was
shown to conceive a semi-constitutive phenotype (Text S1). This,
and given the fact that three of them are conserved in XylR and
DmpR (which do not react to 2-HBP), might suggest that the
identified critical residues (e.g., Thr52, Ile180, Glu184 and
Cys187) not so much directly ‘bind’ 2-HBP but are somehow
important in transmitting an effector-interaction to activation of
the transcriptional regulator. This for XylR and DmpR would
consist of derepressing the ATPase activity, but for HbpR might
consist of activating it [17].
Again, very suggestively but of potential importance for a novel
activation mechanism concept, the observed predicted cavity enters
into an opening the A-domain of HbpR (Fig. 1C). HbpR’s A-domain
is a little shorter at its C-terminal end and extends less into the B-
linker than for XylR or DmpR, which makes this cavity more
pronounced. Although the cavity is not visible in the XylR A-domain
model as proposed by Devos [22], this is only because of the C-
terminal extension of 12 residues in their model. Removal of the C-
terminal beta-sheet shows that the XylR A-domain also adopts such
a cavity and produces an opening (Fig. 1D). Obviously, this part of
the modeling is highly speculative, because the A-domain part of the
protein connects to the C-domain via the proposed flexible B-linker
and this connection loop cannot be properly assigned a structure
without a good template. Modeling of the C-domain of both HbpR
and XylR is possible, because of reasonably high homology (41.2%
for HbpR) to the resolved crystal structure of NtrC1 of Aquifex aeolicus
(PDB entry 1NY5_B). Unfortunately, this homology does not extend
into the B-linker region of some 30 amino acid residues (not shown),
making structure predictions for the connecting region between A-
and C-domains premature. The importance for mentioning this
cavity, however, is that it conceptually would offer a new hypothesis
for effector mediated activation of proteins in this family, which so
far is not solved satisfactorily [31]. Instead of having a classical active
site ‘pocket’, one could imagine that the flexible B-linker region
occludes or ‘opens’ the proposed cavity and opening through which
effectors pass, and that this triggers an intramolecular conforma-
tional change needed to expose the C-domain ATP-ase and activate
RNA polymerase.
In conclusion, therefore, our results highlight the importance of
a region on the HbpR A-domain for effector (2-HBP) control.
Critical residues for effector control in this region were identified,
some of which are conserved with XylR and DmpR, thus ruling
out a direct role in effector binding. Model predictions were
reasonably correct with experimental data. As a new hypothesis
for effector mediated control on this type of proteins, we propose
a model for activation in which the effector compound would
pass through a surface crevice instead of binding to a pocket and
subsequently being released from the same pocket. Whether or
not the surface crevice needs to be made by a single protomer of
the activator protein or a dimer remains to be determined. Direct
binding studies of radio-actively labeled phenol to the DmpR A-
domain indicated a fraction of up to 0.6 mol substrate bound per
mol protein [32], which could be interpreted as a not yet
saturated system in which one effector molecule would bind one
protomer, or as a slightly oversaturated system in which one
effector molecule binds a protomer dimer. Such a model for a
surface crevice and tunnel would also help to understand the
large variety of mutations that influence effector specificity and
semi-constitutive phenotypes, which have been discovered over
the years in XylR, DmpR and HbpR (Text S1). The reason for
this would be that any mutation in the A-domain that somehow
changes this crevice and permits entry to the tunnel may facilitate
another effector to activate the complex. In addition, it could
provide a mechanistic interpretation for the effector-mediated
activation. The current hypothesis for activation states that only
multimeric forms of XylR or HbpR (hexameric or heptameric,
depending on the model) are capable of activating s54 RNA
polymerase. A plausible mechanistic model for such an activation
process would be a slight conformational change induced in the
hexameric complex by a torsion from a number of effector
molecules passing through the cavity-opening.
Materials and Methods
Strains, media and general growth conditions
E. coli recombinant strains were generally cultivated on Luria
Bertani (LB) medium [33], supplemented with 50 mg/ml kana-
mycin to select for the presence of the plasmid carrying hbpR or its
mutants plus a transcriptional fusion between the HbpR
regulatable PC promoter and egfp. For induction experiments E.
coli strains were incubated in MOPS medium (i.e., per liter, 10 g 3-
(N-morpholino)propanesulfonic acid, 1 g NH4Cl, 0.5 g NaCl,
0.06 g Na2HPO4?2H2O, 0.045 g KH2PO4, 20 mM MgCl2,
1 mM CaCl2, and 2 g glucose, pH 7). Liquid cultures were
generally incubated at 37uC with 180 rpm rotary shaking, except
for induction experiments, which were carried out at 30uC.
Bacterial colonies were grown on LB medium solidified with 1.5%
agar and incubated at 30uC or 37uC.
HbpR activation assays
In order to test HbpR- or HbpR-mutant dependent egfp
activation from the PC promoter in E. coli we applied the protocol
essentially as described previously [30]. Single pure E. coli cultures
were grown for 16 h at 37uC in LB medium plus kanamycin and
diluted fifty fold in fresh medium of the same. Cells were regrown
until the turbidity in the culture reached 0.4 (at 600 nm), after
which they were centrifuged at 2,5006 g and resuspended in the
same volume of MOPS buffer. This cell suspension was used for
induction assays. For induction, 200 ml of E. coli cell suspension
was mixed with the effector (20 mM 2-HBP, 100 mM 2-
chlorobiphenyl) in a 96-well microtitre plate. Plates were
incubated at 30uC with 180 rpm rotary shaking for periods of 2
and 4 h, after which the EGFP fluorescence signal was measured
per fluorimetry (FluoStar Galaxy, BMG Labtech GmbH, Offen-
burg, Germany). Incubations with dimethylsulfoxide and water
only served as negative, non-induced controls. Assays were
performed in triplicate. Induction experiments with 20 mM
toluene were carried out in 2 ml glass vials closed by Teflon-
lined caps to avoid evaporation. In this case 0.2 ml of the cell
suspensions was transferred after 2 and 4 h into a 96-well
microtitre plate for fluorescence measurements.
DNA cloning techniques and DNA sequencing
Recombinant DNA techniques were all carried out according to
well-established procedures [33]. PCR mutagenesis mixtures were
prepared as suggested by the suppliers of the Pfu Polymerase
(Promega) and run on GeneAmp PCR System thermocyclers
(Applied Biosystems, CA, USA). DNA was sequenced using the
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BigDye Terminator cycling method (v3.1, Applied Biosystems)
and analyzed on ABI Prism 3100 capillary sequencers (Applied
Biosystems). Kits for purification of PCR products or of DNA
fragments from agarose gels, and for isolation of plasmid DNAs
from E. coli were used according to the specifications given by the
suppliers (Qiagen, Promega).
Chemical substances
2-hydroxybiphenyl (2-HBP), 2-chlorobiphenyl and toluene were
obtained from Sigma-Aldrich. Stock solutions were prepared at
20 mM in dimethylsulfoxide, which were kept at 4uC in the dark.
All other chemicals were of the highest purity grade available.
Bioinformatics analyses
Common bioinformatics analyses were performed using tools
provided by the ExPASy (Expert Protein Analysis System)
proteomics server of the Swiss Institute of Bioinformatics (SIB)
with default settings (http://swissmodel.expasy.org). The 218 first
amino acids corresponding to the A-domain of the HbpR protein
were structurally aligned using MAGIC-FIT to a pdb-model of those
of XylR and DmpR (http://www.pdg.cnb.uam.es/XylR), and
further refined with the help of the online Workspace program
SWISS-MODEL [26,27]. Further three-dimensional analyses were
conducted using the DeepView/Swiss-Pdbviewer program version
4.01 for OS.X [26].
Docking
Hypothetical docking positions of 2-HBP on HbpR were
computed using the GRAMM program (Global Range Molecular
Matching, [28]). The three-dimensional HbpR A-domain model
and the 2-HBP pdb-files were submitted to GRAMM with the
following parameters: Matching mode = generic; grid step = 1.7;
repulsion = 20.0; Attraction double range = 0.0; Potential range
type = atom_radius; black white projection; representation = all;
1000 output matches, angle for rotation = 10.
Site-directed hbpR mutagenesis
Site-directed HbpR mutants were constructed by PCR by using
two different methods. In the first method, the hbpR gene was
amplified in two parts independently by PCR, the junction of
which carried the desired mutation. One fragment was am-
plified with the forward primer 040101 (A-domain For: 59-
gtcgacgcggccgcgcactttcgcacg-39) and the reverse oligonucleotide
carrying the desired mutation, whereas the second fragment was
amplified using the reverse primer 040102 (A-domain Rev: 59-
tgcgcatgctcggaggatccggtttca-39) and the forward complementary
mutated oligonucleotide (Text S1). The two first PCR products
were used as template for a second PCR reaction in which the two
external primers 040101 and 040102 were used. PCRs fragments
were separated on agarose gel and fragments of the proper size
were purified by gel extraction (Qiagen). Purified PCR fragments
were digested by SacI and BamHI and used to replace wild-type
hbpR in the egfp expression plasmid pHBP269A0 to test the
inducibility of the mutants for biaromatic compounds [30]. This
plasmid carries hbpR under its own promoter and egfp under the
control of the PC promoter. Moreover, the 59 part of hbpR is
modified to introduce 6 His-codons in the protein, after which the
regular first Met-codon of HbpR is maintained. Plasmids were
transformed into E. coli DH5a and re-extracted from transfor-
mants to confirm the introduced mutation by DNA sequencing.
Six HbpR mutants (Ile180Thr, Glu183Gln, Glu184Leu,
Ile185Thr, Glu203Leu and Trp205His) were constructed using
this technique.
The other HbpR mutants were created by a method in which
the whole plasmid was amplified by two reverse complementary
primers carrying the mutations. For this purpose, we first cloned
the hbpR A-domain gene region separately. The gene region with
the A-domain was amplified by using the polymerase chain
reaction and primers 040101 and 040102 (PCR cycle: 94uC for
2 min, followed by 25 cycles of each: 94uC for 2 min; 56uC for
30 sec; 72uC for 1 min). The PCR product was digested by SacI
and BamHI and cloned into pUC18 digested by the same enzymes.
pUC carrying the cloned A-domain gene fragment of hbpR was
used as template for the mutagenic PCRs. These PCR was
performed by using Pfu DNA polymerase mix and the following
cycling regime: 94uC for 30 sec, followed by 16 or 18 cycles of
each: 94uC for 30 sec; 55uC for 1 min; 68uC for 2 min.
The fully PCR-amplified plasmid was treated with DpnI to
remove parental (methylated) template plasmid and was then
directly transformed into E. coli DH5a, during which the single-
stranded breaks created by the PCR are repaired. Plasmids from
potential transformants were purified and sequenced to confirm
the mutation. In case of successful mutation, the A-domain gene
regions were recovered by SacI and BamHI digestion, and used to
replace the hbpR wild-type A-domain sequence on pHBP269A0.
After transformation in E. coli, those plasmids were again purifed
and verified for the integrity of the introduced mutation. If correct,
the strains were used to test inducible egfp expression by 2-HBP
from the HbpR controlled PC -promoter.
All hbpR mutant genes in pHBP269A0 subsequently trans-
formed into an E. coli carrying the compatible plasmid pHBP124
with wild-type hbpR expressed from its native promoter [34], in
order to test dominance of the created mutation.
HbpR and HbpR mutant purification
HbpR and HbpR mutants were overexpressed and purified
from E. coli. Hereto we fused the hbpR start codon to the ATG
triplet present in the NdeI site of pET15d (Stratagene). This will
produce an N-terminal His6-tag to hbpR. The hbpR gene was first
amplified from the P. azelaica HBP1 chromosomal DNA by PCR
with primers NdeI-HbpR (59-GCCATATGAAATCAAATAAA-
AATAATAGCGAC- 39; The NdeI site is underlined) and BamH1-
HbpR (59-GCGGATCCTATGTGATCTTTTTGACGCGGT-
39; the BamHI site is underlined). The 1710-bp PCR product
was digested by NdeI and BamHI and ligated to pET15, digested
with the same enzymes. After transformation into E. coli BL21
(DE3) this resulted in plasmid pHBP240. The integrity of the hbpR
open reading frame was verified by DNA sequencing.
E. coli BL21(DE3) containing pHBP240 was grown at 30uC in
LB medium to an optical density at 600 nm of 0.6. To induce T7
RNA polymerase expression isopropyl-b-D-thiogalactopyranoside
was added at a concentration of 1 mM, and cultures were further
incubated overnight at 20uC. Cells were then collected by
centrifugation for 5 min at 12,0006g, washed in the same volume
of buffer containing 20 mM Tris-HCl and 2 mM EDTA (pH 7),
and again centrifuged. The bacterial pellet was resuspended in 1/
10 volume of lysis buffer (50 mM NaH2PO4, 300 mM NaCl,
10 mM imidazole, 5 mM b-mercapto-ethanol, pH 7.5) containing
2,5 mM of Pefabloc SC (4-2-aminoethyl-benzenesulfonyl fluoride,
Roche) as protease inhibitor, and subjected to ultrasonication for
five times during 20 seconds each at 60% and 40 W output
(Branson 450 Sonifier). The cell extract was centrifuged for 30 min
at 8,0006 g to remove cell debris. The supernatant (1/10 volume)
was mixed with 1 ml of 50% Ni-NTA agarose (Qiagen) during
2 hours with stirring at 4uC, and the mixture was loaded on a
polypropylene column (1 ml, Qiagen) equilibrated with 600 ml
lysis buffer. After loading, the column was washed three times with
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4 ml of washing buffer (2 mM EDTA, 300 mM NaCl, 5 mM b-
mercapto-ethanol, pH 7.5) containing increasing amounts of
imidazole (25 mM, 50 mM and 75 mM). His6-HbpR and any
of the His6-HbpR mutants were eluted with elution buffer
(50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, 5 mM
b mercapto-ethanol). Fractions of 0.5 ml were collected and
analysed by conventional sodium dodecyl sulfate polyacrylamide
gel electrophoresis. Fractions with the highest concentration of
purified His6-HbpR protein were pooled and dialyzed overnight
against dialysis buffer (10 mM Tris HCl, 20 mM KCl, 1 mM
EDTA, 10% glycerol).
Protein electrophoresis and immunoblotting
E. coli cultures expressing HbpR or mutant HbpR-s from
pHBP269A0-configurations (see above) were cultured in 5 ml LB
at 30uC to an OD of 0.5, after which cells were harvested by
centrifugation from 1.5 ml. Cell pellets were resuspended in 50 ml
of PBS solution, to which 50 ml of reducing 2xSDS sample buffer
was added (120 mM Tris-HCl [pH 6.8], 2% [w/v] SDS, 10% [v/
v] glycerol, 0.01% [w/v] bromophenol blue, 2% [v/v] 2-
mercaptoethanol). Protein extracts were prepared by boiling the
cell-loading buffer mixtures for 10 min. Appropriate volumes were
loading on denaturing SDS-PAGE, containing 4% stacking and
8% separating gels (acrylamide:bisacrylamide 29:1; Bio-Rad),
using the MiniProtean electrophoresis system (Bio-Rad) according
to standard protocols [33,35]. For immunoblotting, the proteins
were transferred to polyvinylidene difluoride membranes (Im-
mobilon, Millipore) using a semi-dry electrophoresis transfer
apparatus (Bio-Rad) and then blocked in PBS buffer containing
3% skimmed milk and 0.1% Tween-20 for 1 h.
Because commercial anti-His-antibodies were not sufficiently
sensitive to detect His6-HbpR expression in E. coli from the native
PR-promoter, we used an M13-nanobody carrying antigen-
binding part of camel antibodies (VHH) [36]. Purified HbpR was
used to immunize an African camel and after a 6 week period,
RNA was extracted from lymphocytes and retrotranscribed to
DNA. Sequences corresponding to the antigen-binding domain
were amplified and cloned in a phage display vector. Phage
libraries were screened multiple times by phage-ELISA for the best
binder, which was kept as a stock producer of the anti-HbpR
M13-VHH phagebody, as described in Zafra et al [36].
Membranes for Western were placed in phage suspensions diluted
1/1000 of the pool of M13 particles apically presenting VHH
domains for detection of HbpR protein in a PBS buffer
supplemented with 3% skimmed milk, 0.1% Tween-20 and
0.1% sodium deoxycholate, followed by a 45 min incubation at
room temperature with mild shaking. Unbound phages were
washed out with four 5 min rinses with the same PBS/Tween-20/
sodium deoxycholate buffer but devoid of milk. After washing with
PBS, M13 capsids bound to the blotted proteins were detected by
immersion of the membrane in a 1/5000 dilution of HRP/anti-
M13 Monoclonal Conjugate and revealed with the BM chemilu-
miniscence Blotting Substrate-POD kit (Roche). Alter 1 min
incubation in the dark, the blots were exposed to X-OMAT X-
ray film (Kodak).
Gels were scanned and band intensities were corrected for the
total intensity of protein bands on the corresponding SDS-PAGE
Coomassie Blue stained gels, and then normalized for exposure
differences by dividing by the mean band intensity. An average
normalized intensity was then calculated on the basis of both the
HbpR bands visible in Western. All average normalized intensities
of HbpR mutants were then plotted in a Box-plot, to identify
outliers below the 25% and above the 75% quantiles (Text S1).
Circular dichroism
The CD spectrum of purified His6-HbpR or of its mutants was
obtained from a J810 spectropolarimeter (Jasco, Tokyo, Japan)
using a quartz cell with a 0.1-cm path length (L). CD spectra (h,
milli-degree) were measured at 25uC between 195 and 250 nm at
a scanning speed of 10 nm/min and a protein concentration of
<0.3 mg/ml. After subtracting the spectrum from background
generated from buffer alone, the spectra for HbpR and its mutants
were normalized to delta epsilons (De, mdegree?M21?cm21), using
the protein concentration (c, mg?ml21) and the mean residue
weight of HbpR (MRW), via the formula (http://dichroweb.cryst.
bbk.ac.uk/html/userguide.shtml):
De~ h : 0:1:MRWð Þ= 3298:c:Lð Þ
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